Foundation News

Please read through this section of our website to learn more about what's "new" at the Foundation.
 
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr. Anil Adisesh at Dalhousie Medicine New Brunswick, Dalhousie University, and Dr. Trevor Dummer at the Centre of Excellence in Cancer Prevention, within the School of Population and Public Health at the University of British Columbia, will lead a team analyzing the world’s largest collection of toenails, all from Atlantic Canadians, to measure individual exposures to toxic metals that are known carcinogens and may cause prostate cancer. This research is part of a wider strategy by PCC to generate new and practical knowledge in the poorly understood area of prostate cancer prevention.  

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body. Now, Vancouver Prostate Centre (VPC) scientist Dr. Christopher Ong and colleagues have discovered a critical gene that drives cancer growth. From this discovery, they developed a new protein-based medication that prevents unhealthy cell growth that leads to prostate cancer, and potentially other cancers.   Dr. Ong shows support for Prostate Cancer Canada's annual Plaid for Dad fundraiser

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists. The course will be made available in both English and French. The anticipated start date of the course will be April 2018 and the course will be made available for one year after launch. 

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada. Peter will begin effective February 28, 2018.

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men. Professor Robert Day and his team have just discovered a major biochemical mechanism that could hold the key to the disease's progression. The breakthrough, published in Cancer Research, appears so promising that the team is already beginning to work on diagnostic and therapeutic applications.  

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants. Funded by the Movember Foundation and selected by Prostate Cancer Canada (PCC), the winners were chosen based on novel research projects that have the potential to make a significant difference in a number of areas across the spectrum of prostate cancer research. Each grant is worth up to $200,000.  

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.  

Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.   Rocco Rossi at the 2017 Plaid for Dad launch event in Nathan Phillips Square, Toronto

Torys Pedals for Prostate Cancer Canada

From L to R: Michael Pickersgill, Jonathan Weisz, Eileen McMahon, Rocco Rossi, and Denise Ramsden

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples. The discovery also identifies a new opportunity for targeted therapy.

Displaying results 1-10 (of 136)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive